Processa Pharmaceuticals Inc
(PCSA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 0 | 0 | 0 | 0 | 113 |
| Cost of Goods | N/A | N/A | N/A | N/A | 126 |
| Gross Profit | N/A | N/A | N/A | N/A | -13 |
| Operating Expenses | 3,936 | 4,525 | 1,802 | 1,922 | 1,101 |
| Operating Income | -3,936 | -4,525 | -1,802 | -1,922 | -987 |
| Interest Expense | 37 | 161 | 59 | 0 | 236 |
| Other Income | 12 | 18 | 5 | 4 | -1,760 |
| Pre-tax Income | -3,961 | -4,668 | -1,856 | -1,917 | -2,983 |
| Income Tax | -603 | -903 | N/A | N/A | 0 |
| Net Income Continuous | -3,358 | -3,765 | -1,856 | -1,917 | -2,983 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | -371 |
| Net Income | $-3,358 | $-3,765 | $-1,856 | $-1,917 | $-3,354 |
| EPS Basic Total Ops | -350.00 | -355.00 | -210.08 | -245.10 | -7,595.76 |
| EPS Basic Continuous Ops | -303.83 | -353.06 | -199.40 | -228.93 | -6,636.86 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -826.14 |
| EPS Diluted Total Ops | -350.00 | -355.00 | -210.08 | -245.10 | -7,595.76 |
| EPS Diluted Continuous Ops | -303.83 | -353.06 | -199.40 | -228.93 | -6,636.86 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -826.14 |
| EPS Diluted Before Non-Recurring Items | -350.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-3,130 | $-4,517 | $-1,777 | $-1,920 | $-748 |